Page last updated: 2024-08-23

cabergoline and Left Ventricular Dysfunction

cabergoline has been researched along with Left Ventricular Dysfunction in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bauersachs, J; Berliner, D; Erschow, S; Haebel, L; Hilfiker-Kleiner, D; Koenig, T; Mueller, JH; Pfeffer, TJ; Ricke-Hoch, M; Scherr, M; Talbot, SR; Yalman, KC; Zwadlo, C1
Becher, H; Herring, N; Karavitaki, N; Szmigielski, C; Wass, JA1
Bouma, BJ; de Jong, JS; Rietveld, K; van Lochem, LT1
Bridgman, P; Cawood, TJ; Cole, D; Hunter, L1

Other Studies

4 other study(ies) available for cabergoline and Left Ventricular Dysfunction

ArticleYear
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    ESC heart failure, 2023, Volume: 10, Issue:1

    Topics: Animals; Bromocriptine; Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Mice; MicroRNAs; Myocytes, Cardiac; Peripartum Period; Pregnancy; Prolactin; Ventricular Dysfunction, Left

2023
Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
    Clinical endocrinology, 2009, Volume: 70, Issue:1

    Topics: Aortic Valve Insufficiency; Cabergoline; Calcinosis; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Prolactinoma; Ventricular Dysfunction, Left

2009
Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy.
    European journal of heart failure, 2009, Volume: 11, Issue:2

    Topics: Adult; Cabergoline; Cardiomyopathies; Echocardiography; Ergolines; Female; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Pregnancy; Prolactin; Puerperal Disorders; Ventricular Dysfunction, Left

2009
Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma.
    Internal medicine journal, 2009, Volume: 39, Issue:4

    Topics: Brain Ischemia; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Fatal Outcome; Fibrosis; Heart Valve Prosthesis Implantation; Humans; Intestinal Obstruction; Male; Middle Aged; Mitral Valve Insufficiency; Pituitary Neoplasms; Prolactinoma; Tricuspid Valve Insufficiency; Ventricular Dysfunction, Left

2009